Keywords:
MR, Cardiac, MR-Diffusion/Perfusion, Computer Applications-Detection, diagnosis, Contrast agent-intravenous, Diagnostic procedure, Inflammation, Hyperplasia / Hypertrophy, Haematologic diseases
Authors:
C. Cholet1, J. Mayer1, F. Legou1, F. Ridouani2, T. Damy2, A. Luciani1, H. Kobeiter1, A. Rahmouni1, J. F. Deux1; 1Créteil/FR, 2Paris/FR
Results
- Myocardial SI measured before injection:
Short axis view:
Myocardial SI of patients with SA was significantly higher than patients with CA (p=0.04) and control group (p=0.001).
Four chamber view:
Myocardial SI of patients with SA was significantly higher than patients with CA and control group (p=0.02 each).
- Myocardial SI measured after injection:
Short axis view:
Myocardial SI was significantly higher in patient with CA and SA than in control groups (p<0.05).
No significant difference was found between patients with CA and patients with SA.
Four chamber view:
Myocardial SI was significantly higher in patient with CA and SA than in control groups (p<0.05).
No significant difference was found between patients with CA and patients with SA.
- Percentage of myocardial enhancement:
Patients with CA exhibited a significantly higher percentage of myocardial enhancement in comparison to other groups (with p=0.02 between CA and control groups,
and p=0.07 between CA and SA groups).
No significant difference was found between patients with CA and patients with SA.
LVEF was significantly lower in patients with CA than in patients with SA or control patients,
with p=0.04.
No significant difference was found between patients with SA and control patients.
Myocardial thickness was significantly more important in patients with CA than in patients with SA or control patients (p=0.001).
No significant difference was found between patients with SA and control patients.